This brand name is authorized in Brazil, Ecuador, France, Spain.
The drug AGRASTAT contains one active pharmaceutical ingredient (API):
1
|
UNII
6H925F8O5J - TIROFIBAN HYDROCHLORIDE
|
|
Tirofiban is a non-peptidal antagonist of the GP IIb/IIIa receptor, an important platelet surface receptor involved in platelet aggregation. Tirofiban prevents fibrinogen from binding to the GP IIb/IIIa receptor, thus blocking platelet aggregation. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| B01AC17 | Tirofiban | B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 505609401151317 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 360040512 |
| ES | Centro de información online de medicamentos de la AEMPS | 62713, 62714 |
| FR | Base de données publique des médicaments | 65024764, 66766366 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.